Nevertheless, in ≥60% of T-ALL patients, c-Myc is overexpressed downstream of activated Neurogenic locus notch homolog protein 1 (NOTCH1) mutations and plays a key role in disease induction and aggressiveness [121]. The gene discussed is MYC; the disease is acute lymphoblastic leukemia.